Should You Buy Equitable Holdings Inc (EQH) Today? Analysis, Price Targets, and 2026 Outlook.
Analysis Updated At
2026/01/28
EQH is not a good buy right now for a beginner long-term investor who wants to enter immediately. The stock is in a bearish technical structure (200-day > 20-day > 5-day, MACD still negative), and the latest provided quarter snapshot shows sharp YoY revenue and margin deterioration. While Wall Street remains broadly constructive (multiple Overweight/Outperform ratings with targets well above the current ~$46) and hedge funds have been accumulating, the current trend/financial momentum combination does not justify an immediate long-term entry at this moment. I would hold off and reassess after the Feb 4 earnings release.
Technical Analysis
Price/Trend: Bearish trend structure with moving averages stacked negatively (SMA_200 > SMA_20 > SMA_5), signaling the path of least resistance is still down. Momentum: MACD histogram is -0.186 (below zero) but negatively contracting, implying downside momentum is weakening, not yet reversed. RSI(6) at ~43 is neutral-to-weak (not oversold). Levels: Pivot 46.506 is just above the post-market price (~46.11), so the stock is trading slightly below its pivot; near-term support sits at S1 45.284 then S2 44.529, while resistance is R1 47.729 and R2 48.484. Net: This setup favors “prove-it” upside before calling it a fresh long-term buy.
Analyst Ratings and Price Target Trends
Recent trend: Price targets have been trimmed modestly (e.g., Barclays $63→$58; JPMorgan $64→$60; Morgan Stanley $61→$59; KBW $65→$63), but ratings skew positive and JPMorgan upgraded to Overweight (from Neutral). Mizuho initiated with Outperform and a $66 target. Wall Street pros view (pros): undervaluation vs peers, solid balance sheets/capital strength, and improving operating outlook for life insurers in a favorable macro. Cons view (cons): spread compression risk, higher tech spend, and credit-quality deterioration risk in corporate credit that could weigh on life insurers.
Wall Street analysts forecast EQH stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for EQH is 61.43 USD with a low forecast of 58 USD and a high forecast of 66 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Wall Street analysts forecast EQH stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for EQH is 61.43 USD with a low forecast of 58 USD and a high forecast of 66 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Current: 46.110
Current: 46.110
